Related Experiment Videos
Primary subclavian-axillary vein thrombosis: consensus and commentary
1Section of Vascular Surgery, University of Colorado School of Medicine, Denver, USA.
Cardiovascular Surgery (London, England)
|August 1, 1996
Summary
Vascular surgeons recommend early clot removal and catheter-directed thrombolysis for subclavian-axillary vein thrombosis. Treatment decisions for residual blockages vary, with a preference for jugular vein turndown over first rib removal.
Area of Science:
- Vascular Surgery
- Venous Thromboembolism Management
Background:
- Subclavian-axillary vein thrombosis (SCVT) presents complex management challenges.
- Optimal treatment strategies require expert consensus.
Framework:
- A panel of vascular surgery experts discussed and voted on 15 multiple-choice questions regarding SVT management.
- The study involved 25 vascular surgeons specializing in venous disease.
Implementation:
- Majority favored early clot removal for active patients and catheter-directed thrombolysis as initial therapy.
- Follow-up positional venography guides further treatment, including surgical relief for thoracic outlet compression.
- Conservative therapy is recommended for minor residual occlusion or no extrinsic compression post-thrombolysis.
Implications:
- Intervention is advised for residual intrinsic lesions exceeding 50% narrowing.
- Significant divergence exists regarding the optimal intervention for residual stenoses, with divided opinions on surgical versus percutaneous transluminal angioplasty.
- Jugular vein turndown is favored for residual symptomatic occlusion over first rib removal.